| Code | 9924D | ||||||||||
| MA number | 09/0062/22-S | ||||||||||
| Product Form: | cps end 14x20 mg (blis.OPA/Al/PE+DES film/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 22.03.2022 |
| Validity: | 22.03.2027 |
| PIL: |
PIL_Esozoll 20 mg cps end_03 2022.pdf
|
| SPC: |
SPC_Esozoll 20 mg cps end_03 2022.pdf
|
| Safety feature | No |
| Data update: | 24.03.2022 |
